All of the following are true regarding Bedaquiline use except

BEDAQUILINEPatient should be using non- hormonal based bih control measure throughout the treatment period The basic criteria for patient selection for bedaquiline is : Age of the patient should be >=18 years having MDR- TB Pregnancy is a contraindication for BDQ therapy and the patient should be using non-hormonal based bih control measure throughout the treatment period or have been postmenopausal for past 2 years; and Cardiac arrhythmia is a contraindication for BDQ treatment -XDR-TB patient is eligible for therapy